Thus, in HER2+ breast tumors, HER2 promotes progression when it changes its transcription and amplification, as it mediates the transduction signal by heterodimer and the autophosphorylation of tyrosine kinase, resulting in the activation of key cascade pathways Ras/MAPK and PI3K/Akt. This evidence concerns the gene ERBB2 and breast neoplasm.